Production of Biologically Derived Small Molecule Regulatory Starting Materials and/or Active Pharmaceutical Ingredients at Commercial Scale
Agency: | |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159606282795516 |
Posted Date: | Jan 17, 2024 |
Due Date: | Feb 1, 2024 |
Source: | https://sam.gov/opp/495d3e9689... |
- Contract Opportunity Type: Special Notice (Original)
- All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: Jan 16, 2024 03:06 pm EST
- Original Response Date: Feb 01, 2024 01:00 pm EST
- Inactive Policy: 15 days after response date
- Original Inactive Date: Feb 16, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code:
- NAICS Code:
-
Place of Performance:
Summerville , SCUSA
ASPR IBMSC through the BARDA PCI BioMaP-Consortium is seeking to develop a biological design-build-test cycle at population scale, beginning with an analytical/paper demonstration of production of small molecule drug substances at commercial scale. This objective will support ASPR IBMSC’s broader long-term goal of developing and commercializing infrastructure that will be accessible to a broad community of users for the purpose of three biologically derived small molecule drug substances, creating a new manufacturing paradigm that can be competitive in the global market and to onshore drug production. The objective of this project is to demonstrate the ability to produce three (3) biologically derived small molecule drug substances at population scale.
You can find the solicitation on the BioMaP-Consortium website here: https://www.biomap-consortium.org/24-01-smallmol/.
Submissions must be made through the BioMaP-Consortium website ONLY.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Jan 16, 2024 03:06 pm ESTSpecial Notice (Original)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.